Non-nucleotide composition for inhibiting platelet aggregation
US7943760B2 · kind B2 · utility
Assignee
Inventors
Key dates
| Filing date | Sep 2, 2009 |
| Grant date | May 17, 2011 |
| Priority date | — |
| Expiry date | Sep 2, 2029 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61F2250/0067
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
This invention is directed to a method of preventing or treating diseases or conditions associated with platelet aggregation. The method is also directed to a method of treating thrombosis or related disorders. The method comprises administering to a subject a pharmaceutical composition comprising an effective amount of a non-nucleotide compound, preferably a P2Y12 receptor antagonist compound, wherein said amount is effective to inhibit platelet aggregation. The compounds useful for this invention include compounds of general Formulae I and III-XII, or salts, hydrates, and solvates thereof. The present invention also provides novel compounds of Formulae I and III-XII.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.